Department of Rheumatology, Université de Lille, Centre Hospitalier Universitaire de Lille, Lille, France.
Department of Medicine, Cambridge Biomedical Campus, Cambridge, UK.
Lancet Diabetes Endocrinol. 2024 Oct;12(10):748-760. doi: 10.1016/S2213-8587(24)00163-3. Epub 2024 Jul 22.
Obesity and its associated comorbidities constitute a serious and growing public health burden. Fractures affect a substantial proportion of people with obesity and result from reduced bone strength relative to increased mechanical loading, together with an increased risk of falls. Factors contributing to fractures in people with obesity include adverse effects of adipose tissue on bone and muscle and, in many people, the coexistence of type 2 diabetes. Strategies to reduce weight include calorie-restricted diets, exercise, bariatric surgery, and pharmacological interventions with GLP-1 receptor agonists. However, although weight loss in people with obesity has many health benefits, it can also have adverse skeletal effects, with increased bone loss and fracture risk. Priorities for future research include the development of effective approaches to reduce fracture risk in people with obesity and the investigation of the effects of GLP-1 receptor agonists on bone loss resulting from weight reduction.
肥胖及其相关合并症构成了严重且日益严重的公共卫生负担。骨折影响了相当一部分肥胖人群,其原因是骨强度相对于机械负荷的增加而降低,同时跌倒的风险增加。导致肥胖人群骨折的因素包括脂肪组织对骨骼和肌肉的不良影响,以及在许多人中 2 型糖尿病的共存。减肥策略包括限制热量的饮食、运动、减重手术和 GLP-1 受体激动剂的药物干预。然而,尽管肥胖人群的体重减轻有许多健康益处,但它也会对骨骼产生不良影响,导致骨丢失和骨折风险增加。未来研究的重点包括开发有效方法来降低肥胖人群的骨折风险,以及研究 GLP-1 受体激动剂对减肥引起的骨丢失的影响。